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The isoﬂavone irilone is found in human plasma after ingestion of red
clover-based dietary supplements, but information allowing safety
assessment is rare. Here, data in support of the mutagenic potential
of irilone in cultured V79 cells [1] are presented. These data include
(i) a quantitative assessment of irilone in the culture medium during
the cell culture experiments, (ii) changes in the mutation spectrum in
cDNA of the hypoxanthine-guanine phosphoribosyltransferase locus
of irilone-treated V79 cells, (iii) occurrence of karyorrhexis and
apoptosis as well as (iv) number of micronucleated cells containing
whole chromosomes or chromosomal fragments. Also exemplary
micrographs, used for the ﬂuorescence microscopic assessment of
(iii) and (iv) are presented.
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cubation were observDNA sequencing by Sanger method at LGC Genomics, Germany,Observer Z1 ﬂuorescence microscope
(Zeiss, Germany) equipped with a Plan-Apochromat objective 63x/1.4 Oil DICData format Raw (micronucleus data), analyzed (DNA sequencing, irilone in culture medium), and micrograph
Experimental factors Cultured Chinese hamster V79 ﬁbroblasts were treated with irilone. For cDNA sequencing total RNA
was isolated from cloned mutants selected from irilone-treated, cultured Chinese hamster V79
ﬁbroblasts, reversely transcribed, and ampliﬁed. For micronucleus data, cells were ﬁxed, α-tubulin
(Cy3), and centromere proteins (FITC) were stained immunochemically. DNA was stained with DAPIExperimental
featuresIrilone in cell culture medium was quantiﬁed by HPLC-DAD. Mutation spectrum in cDNA of irilone-
treated V79 cells was determined by Sanger method. Apoptosis, karyorrhexis, and micronucleus
formation were assessed by ﬂuorescence microscopy.Data source location
Data accessibility Data are with this article only.Value of the data Speciﬁes mutation spectra and detailed discussion thereof.
 Complements data on mutagenicity, and cytotoxicity of irilone.
 Provides extensive raw data on time course of micronuclei formation observed with positive
controls and irilone
 Methodical insight into scoring criteria for ﬂuorescence microscopic evaluationin cell culture medium after the incubation period in the hypoxanthine-guanine phosphoribosyl-
y (24 h, upper panel) and in the micronucleus test (6 h, lower panel). Prior to incubation, mean
in medium and standard deviations of at least 3 independent experiments were 4.270.4 mM,
mM, and 32.772.1 μM in HPRT assays, and 2.2 mM (single experiment), 4.171.9 mM, 8.672.5 mM,
.7 μM and 65.9714.1 μM in micronucleus assays. In each experiment, the concentrations after
to the ones before incubation (100%). Data represent means7standard deviations of at least three
ts (6 h, 2 mM, single experiment). No signiﬁcant differences between IRI concentrations before and after
ed (t-test, adjusted p40.05).
Table 1
Mutation spectra of Hprt cDNAs derived from 6-thioguanine (6-TG)-resistant colonies selected from V79 cell populations
treated with solvent (1% DMSO) or IRI. In each independent HPRT experiment (1, 2, 3), two ﬂasks were treated with solvent
(DMSO1 and DMSO2) and one ﬂask each with various concentrations of IRI. The change in the sequence of cDNA is given in 50-
30direction. Despite sufﬁcient amount and quality of total RNA, 23% of Hprt cDNAs collected after treatment with DMSO yielded
no PCR product, which did not differ statistically from the percentage observed after treatment with 16 mM IRI (18%, p¼0.6166,
Fischer’s exact test). Since the primer binding sites were in the untranslated regions (UTR) ﬂanking exons 1–9 and the mutant
clone was 6-TG-resistant, no PCR product can only be due to complete lack of Hprt cDNA or deletions affecting one or more
exons together with one or both primer binding sites. Thus, mutants not yielding a PCR product were scored “deletions of
UTRþexons (UTRþ?)”. The same mutation at the same locus in cDNA extracted from colonies of the same V79 cell population
(i.e. one ﬂask) may be due to the same event and were therefore counted only once for the determination of the spectra of
certain independent mutations (Σi). In the table, each independent mutation is highlighted by a grey background, thus the
number of grey rectangles per treatment group corresponds to Σi. Statistical comparison of complete mutation spectra (Σ, Σi)
was performed according to [2].
Position Change in sequence Number of mutations
Exon Bp cDNA Amino acid DMSO1 DMSO2 IRI 16 mM IRI 4 lM IRI 33 lM
1 2 3 1 2 3 1 2 3 3 3
1 81 ACC-ACG Thr-Thr 0 0 0 0 1 0 0 0 0 0 0
3 241 CGA-TGA Arg-Stop 0 0 0 0 0 0 0 0 0 1 0
6 493 GAT-AAT Asp-Asn 0 5 2 0 0 2 0 0 0 0 0
6 499 ATT-TTT Ile-Phe 0 0 0 2 0 0 0 0 0 0 0
6 505 ACT-CCT Thr-Pro 1 0 0 0 0 0 0 0 0 0 0
7 584 GTG-GGG Val-Gly 0 0 0 0 4 0 0 0 0 0 0
8 631 TTT-ATT Phe-Ile 0 0 0 1 0 0 0 0 0 0 0
8 662 TAT-TGT Tyr-Cys 0 0 0 3 0 0 0 0 0 0 0
8 681 GAG-GAC Glu-Asp 1 0 0 0 0 0 0 0 0 0 0
9 707 TGT-TAT Cys-Tyr 0 0 0 1 0 0 0 0 0 0 0
3 405/406 Insertion C 0 0 0 0 0 0 1 0 0 0 0
8/9 699/700 Insertion G 0 0 0 0 0 0 0 1 0 0 0
2þ3 109–409 Deletion Deletion 0 0 0 0 0 2 0 3 0 0 0
2 110–225 Deletion Deletion 00 0 0 0 0 0 1 0 0 0 0
4 413–478 Deletion Deletion 7 0 9 2 3 5 10 7 5 8 7
6 493–575 Deletion Deletion 0 0 0 0 0 3 0 0 0 0 0
UTRþ? ? Deletion Deletion 3 7 1 3 2 0 0 1 5 3 5
Σ36 (Σi 9) Σ34 (Σi 14) Σ34 (Σi 9) Σ12 (Σi 3) Σ12 (Σi 2)
p Value of comparison Σ treatment group vs. Σ DMSO1þ2 0.67059 0.84118 0.02941 0.357060 0.70177
p Value of comparison Σi treatment group vs. Σi DMSO1þ2 1.00000 1.00000 0.66353 – –
A. Schefﬂer et al. / Data in Brief 4 (2015) 474–4874761. Data
1.1. Stability of irilone (IRI) under experimental incubation conditions
To evaluate the stability of IRI in cell culture medium under incubation conditions, aliquots of
incubation media were either sampled immediately or at the end of the treatment period and
concentrations of IRI were quantiﬁed by HPLC–UV: Concentrations of IRI in the culture media at the
end of the treatment period of both the HPRT and micronucleus assay were not statistically different
from that before treatment, yet mean values were slightly decreased (Fig. 1). Therefore, extensive
chemical or enzyme-induced instability of IRI can be excluded.1.2. Mutation spectra of IRI-induced V79 mutants
The mutation spectra of IRI-induced mutants formed during the hypoxanthine-guanine
phosphoribosyltransferase (HPRT) assay in cultured V79 cells was investigated. Assuming that
resistance of mutants to 6-TG has got to be reﬂected at Hprt mRNA level, the mutation spectra of Hprt
cDNAs were determined. Thus, a minimum of ten 6-TG-resistant colonies derived from solvent- and
IRI-treated cell populations were chosen randomly during each independent HPRT assay, cloned, total
RNA was isolated, mRNA was reversely transcribed, cDNA was ampliﬁed by PCR, the ampliﬁcation
A. Schefﬂer et al. / Data in Brief 4 (2015) 474–487 477product puriﬁed, and sequenced by Sanger method. Thus, a total of 70 cDNAs, derived from 6-TG-
resistant colonies of the populations treated with DMSO and 34 cDNAs, derived from populations
treated with 16 mM IRI were analyzed. Each cDNA exhibited at least one mutation, i.e. deletions of
exons 2–3, 4, 6, and of untranslated regionþexons, transitions, and þ1-frameshift mutations
(Table 1). Mutation spectrum of 6-TG-resistant mutants derived from cells of the solvent control were
characterized by exon deletions (67%) and base pair substitutions (33%, Table 1).
After treatment with 4 mM IRI the mutation spectrum of Hprt cDNAs exhibited one transition
besides exon deletions (not observed in a total of 46 cDNAs obtained from populations treated with 16
and 33 mM IRI) and did not differ from that observed in control cells. In contrast, Hprt cDNA derived
from cells treated with 33 mM IRI exhibited exclusively exon deletions and differed signiﬁcantly from
that observed in control Hprt cDNA (Table 1).
Comparison of spontaneously occurring mutation spectrumwith published data was hindered due
to methodical differences and variation between V79 cell lines: analysis of Hprt exons 1–9 of 30 and
40 DNAs derived from a V79 cell line originating in the same laboratory as the one used in the present
study, revealed that exon deletions accounted for 40% [3] and 53% [4] of total mutations, respectively.
However, at cDNA level, deletions are not only caused by exon deletions but also by base pair
substitution(s), frameshift mutations and other events [5].
Thus, the proportion of exon deletions at cDNA level observed in the present study (67%) is
probably lower at DNA level and thus comparable or even lower than that observed at DNA level with
the same V9 MZ, yet higher than that determined at cDNA level in a V79 cell line of unknown origin.
Since no mutants with deletions in one or more exons of Hprt DNA were observed in the V79-UL cell
population, which is also a “normal” V79 cell line from another laboratory [3,4], big variances between
different V79 cell lines can be expected. It is known that also the response to mutagens differs
between “normal” V79 cell populations [6]. Thus, it can only be stated that the mutation spectrum of
the DMSO-treated, 6-TG resistant V79 cell population in the present study seems not to be unusual for
the V79 MZ population.
The determination of the mutation spectrum had two limitations:(i) two or more identical mutations at the same position of Hprt cDNA were observed in mutants
selected from the same ﬂask. Therefore, mutations were only assumed to be independent, if they
were either at different positions of the Hprt cDNA sequence, occurred in different experiments,
which were performed with a freshly thawed stock of cells, or occurred in cell populations treated
in different ﬂasks during the same HPRT assay. As a consequence, despite sequencing 70 cDNAs
derived from control cell populations and 34 cDNAs derived from populations treated with IRI, the
number of independent mutations for which clonal expansion could be completely excluded was
small (Table 1). Yet, the effect was still obvious without any statistical analysis and reached
statistical signiﬁcance despite the rather small number of observations. Independency of mutations
observed in vitro is deﬁned and dealt with heterogeneously in literature: (a) mentioning the
possibility of clonal expansion in discussion but ignoring it in data analysis (e.g. [7]), (b) deﬁning
mutations to be independent if picked from different petri dishes seeded from the same cell
solution (e.g. [8]), (c) same as (b) and repeating the experiment once, e.g. [3], (d) splitting the
culture after treatment into different ﬂasks (e.g. [9]). Thus, the authors’ approach was the most
conservative one possible, comparable to that of [9].(ii) Hprt cDNAs instead of Hprt exons were sequenced for assessment of mutation spectra. However,
base pair substitutions, frameshift mutations, and deletions in Hprt introns and exons may cause
the same results on cDNA level [5]. Thus, information on the genotoxic mode of action derived
from analysis of Hprt cDNA was not as detailed as the one that would have been derived from
analysis of Hprt exons, and unambiguous information could only be achieved by analysis of both
Hprt exons and introns together. Due to the higher information content, it can be assumed that
analysis of DNAwould detect a shift in mutation spectrum rather more sensitively than analysis of
cDNA. Thus, the observed IRI-induced alteration of the mutation spectrum at cDNA level can be
assumed to be conﬁrmed at DNA level. However, the multiple causes possibly leading to the
observed increase in the proportion of cDNA deletions induced by IRI [1], would render a detailed
Fig. 2. Number of cells exhibiting nuclear fragmentation without (i.e. karyorrhectic, top panel) and with chromatin
condensation (i.e. apoptotic, bottom panel) in V79 cells immediately after treatment with IRI for 6 h and subsequent IRI-free
postincubation for up to 40 h. Data represent sums of minimum three independent experiments, statistically analyzed by
Fisher’s exact test. Different characters signify statistically different data groups at the respective postincubation time (po0.05).
The number of karyorrhectic cells in the population of cells treated with 38 and 66 mM IRI stayed statistically different from
control populations until postincubation for 40 h (information not included in the graph).
A. Schefﬂer et al. / Data in Brief 4 (2015) 474–487478discussion of the putative genotoxic mode of action of IRI and of the cause for the lack of increase
in mutant frequency rather speculative.Although exon deletions at cDNA level are caused by both deletions, base pair substitutions, and
frameshift mutations at DNA level [5], the increase in exon deletions in mutation spectra of 6-TG
resistant V79 cells indicated a clastogenic mode of action, which is known to be detected insufﬁciently
by the Hprt gene mutation assay [10]. Thus, the putatively clastogenic potential of IRI was further
investigated using the micronucleus assay, which responds to both clastogens inducing micronuclei
containing chromosomal fragments (CREST antibody signal-negative micronuclei) and aneugens
inducing micronuclei containing whole chromosomes (CREST antibody signal-positive).
1.3. Fluorescence microscopic assessment of cytotoxicity, apoptosis, and micronuclei formation
As expected, no signiﬁcant increase in the frequency of cells containing nuclear fragments with
condensed chromatin, i.e. apoptotic bodies (Fig. 2), was observed immediately after treatment with IRI
for 6 h (Fig. 2). After IRI-free postincubation for up to 40 h, small increases in the frequencies of cells
with apoptotic bodies were observed after treatment with 38 and 66 mM IRI (maximum 4 and 10 cells/
1000 cells, respectively, at 15 h postincubation, Fig. 2). However, after treatment with 17, 38, and 66 mM
IRI, a strong increase in the frequency of nuclear fragmentation (karyorrhexis) without chromatin
condensation was observed, decreasing during postincubation time and remaining statistically
signiﬁcant until 6 h (38 mM) and 15 h (66 mM) of postincubation (Fig. 2).
In the V79 cell population treated with solvent only, 20–34 cells containing CREST antibody signal-
negative micronuclei (i.e. chromosomal fragments)/3000 cells were observed (Supplemental Table,
and [1]) which lies within the normal range [11]. The aneugen diethylstilbestrol (DES) did not affect
A. Schefﬂer et al. / Data in Brief 4 (2015) 474–487 479the frequency of micronucleated cells with chromosomal fragments at any time point (Supplemental
Table). The occurrence of micronuclei containing chromosomal fragments induced by other positive
controls followed different kinetics: whereas the topoisomerase poison etoposide signiﬁcantly
increased the frequency of cells with CREST antibody signal-negative micronuclei already at 6 h
postincubation time, the DNA-DNA cross-linker mitomycin C and the alkylating agent ethyl
methanesulfonate induced an increase in micronucleated cells at 15 and 24 h, respectively. In cell
populations treated with 38 and 66 mM IRI, a slight but signiﬁcant (po0.05, Fisher’s exact test)
increase in the frequencies of micronucleated cells containing chromosomal fragments at 6–40 h (38
and 66 mM) postincubation time to maximum 53 and 64 micronucleated cells/3000 cells, respectively,
was observed, supporting a weak clastogenic potential of IRI. Although the increase in micronucleated
cells was too small to draw strong conclusions from its time-dependency, a mode of action needing
rather a shorter postincubation period (such as observed with etoposide or mitomycin C) than a
longer postincubation period (as observed with ethyl methanesulfonate) was indicated (Supplemental
Table, and [1]).
After treatment with the known aneugen diethylstilbestrol (15 and 25 mM), the frequency of cells
with micronuclei containing whole chromosomes at 0–15 h postincubation time was increased to
maximum 89 micronucleated cells/3000 cells (25 mM, 6 h postincubation) compared to 2.6–6.1
micronucleated cells/3000 cells observed with the solvent control (Supplemental Table, and [1]).
Likewise, after treatment with 38 and 66 mM IRI, the frequency of micronucleated cells was increased
to maximum 40 (38 mM, 3 h postincubation) and 41 (66 mM, 6 h postincubation) micronucleated cells/
3000 cells (Supplemental Table, and [1]).2. Experimental designs, material and methods
2.1. General cell culture conditions
V79 MZ cells, kindly provided by H. Glatt (German Institute of Human Nutrition, Potsdam,
Germany), were cultured in DMEM supplemented with 100 U/ml penicillin, 100 μg/ml streptomycin,
and 10% fetal calf serum (Invitrogen™ Life Technologies, Germany) referred to as DMEM complete.
Cells were kept at 37 1C in a humidiﬁed atmosphere and 5% CO2.
2.2. Quantitation of IRI in cell culture medium before and after incubation
In each experiment, about 1 ml of the incubation medium (freshly prepared and after incubation)
was ﬂash frozen with liquid nitrogen and stored at 80 1C until analysis. To quantify IRI, the method
previously described for the determination of IRI in dietary supplements [12] was used with slight
modiﬁcations. 2.0 mg internal standard (4,40-isopropylidendiphenol) was added to 250 ml (o10 mM
IRI) or 50 ml (410 mM IRI) medium prior to extraction with ethyl acetate. Organic phases were
collected, evaporated, and the remainder was reconstituted in 50 ml methanol. HPLC analyses were
run on a HP Agilent Series 1100 (Agilent Technologies, Germany) equipped with a diode array
detector. 5 ml reconstituted extract was separated on a C18 phase (Eurospher-100, 2504 mm, 5 μm,
Knauer, Germany) at 1 ml/min using acidiﬁed acetonitrile:water (0.1% formic acid in water (A) and
0.1% formic acid in acetonitrile (B); gradient was from 30% B to 39% B over 54 min and then from 39% B
to 55% B over 16 min), detected by its absorbance at 280 nm and relative peak areas compared to the
calibration curve (24, 44, 64, 84, and 104 ng IRI together with 200 ng internal standard on column).
2.3. Mutation spectrum of IRI treated V79 cells
2.3.1. HPRT assay for the generation of mutants
HPRT assays have been performed as described previously [13] with slight modiﬁcations. 1.5106
V79 cells were seeded in cell culture ﬂasks (175 cm2, Greiner Bio-one, Germany) containing 20 ml
DMEM complete. After 24 h, the medium was changed (day 0) and cells were treated with different
Fig. 3. Hprt primer positions, ampliﬁed and sequenced sequences of Hprt cDNA. Primers (P1 and P2) were positioned in the 30-
and 50-untranslated region (light blue) of Hprt cDNA (reference cDNA sequence: GenBank: J00060.1; http://www.ncbi.nlm.nih.
gov/nuccore/J00060.1) 29 base pairs distant from exon 1 (P1) and 392 base pairs distant from exon 9 (P2). The ﬁrst few base
pairs cannot be analyzed reliably by Sanger sequencing (light green) but base pairs 81 and higher as well as 1105 and lower
were analyzable in every sequencing reaction (green). (For interpretation of the references to color in this ﬁgure legend, the
reader is referred to the web version of this article.)
A. Schefﬂer et al. / Data in Brief 4 (2015) 474–487480concentrations of IRI or 1 mM NQO or 1% DMSO for 24 h. A total of 1106 treated cells were
subcultured in fresh medium directly after treatment (day 1) and again on day 4. On day 6, cells with
mutations at the Hprt gene locus were selected by growing cells in DMEM complete, and 7 mg 6-
thioguanine (6-TG)/ml using three tissue culture dishes (145 mm, Greiner Bio-one) with 1106 cells
per dish.
2.3.2. Cloning of 6-TG-resistant mutants
After 12 days, medium from the dishes containing the Hprt mutants was removed and single Hprt
mutant colonies were trypsinized within sterilized stainless steel rings, placed around single colonies
using silicone grease. Detached cells were transferred into single wells of 6-well plates (NuncTM,
Thermo Fisher Scientiﬁc, Germany) and cultured for another 2–4 days until isolation of total RNA.
2.3.3. RNA isolation and reverse transcription
Total RNA was isolated using the GenElute™ Mammalian Total RNA Miniprep Kit followed by
DNase digestion by DNase I Ampliﬁcation Grade Kit (both kits Sigma-Aldrich) and stored at 80 1C.
One mg total RNA was reversely transcribed using oligo-(dT)18 primer, 10 mM dNTPs, 20 u
RiboLockTM RNase-Inhibitor, and 200 U RevertAidTM Reverse Transcriptase according to the
manufacturer’s instructions (Thermo Scientiﬁc, Germany). cDNA was stored at 20 1C.
2.3.4. Ampliﬁcation, isolation and sequencing of V79 cDNA
Reverse primer 50-ATGAACTGAGTGCTTTCACA-30 (exact positions depicted in Fig. 3) and forward
primer 50-CTTCCTCCTCACACCGCTCT-30 were checked for lack of secondary structures and unspeciﬁc
ampliﬁcation products by PrimerExpress 3.0 – licensed – (Applied Biosystems). Positioning of primers
in the 30- and 50-untranslated region of Hprt cDNA, respectively, ensured reliable sequencing and
duplicate determination of all exons (Fig. 3). 600 ng Hprt cDNA dissolved in nuclease free water and
4 μl forward or reverse primer (5 μM), respectively were mixed in a volume of 14 ml and subjected to
Sanger sequencing by LGC Genomics, Germany.
2.3.5. Analysis of sequencing data and of mutational spectra
Resulting electropherograms were analyzed using Chromas Lite (freely available at http://www.
softpedia.com/get/Science-CAD/Chromas-Lite.shtml) and resulting sequences were compared using
ApE (freely available at http://biologylabs.utah.edu/jorgensen/wayned/ape/) and Referenz Sequenz
cDNA: GenBank: J00060.1; http://www.ncbi.nlm.nih.gov/nuccore/J00060.1. Type and position of
mutations within the cDNA were determined by sequence alignment.
2.4. Micronucleus assay
2.4.1. Cell exposure
V79 cells were grown on chamber slides (Thermo Fisher Scientiﬁc Inc., Germany) with eight
chambers per slide (5–7103 cells/cm2) for 24 h prior to incubation with IRI (ChromaDex™, Irvine,
CA, USA), diethylstilbestrol (Biomol, Germany), etoposide, mitomycin C, and ethyl methanesulfonate
A. Schefﬂer et al. / Data in Brief 4 (2015) 474–487 481(all Sigma-Aldrich, Germany) or with the solvent (1% DMSO) for 6 h with and without subsequent
substance-free incubation for up to 40 h.
2.4.2. Fixation and immunological staining
Following incubation with the test compounds, cells were stained as described previously [14] with
slight modiﬁcations. Cells were ﬁxed with freshly depolymerized 3.5% paraformaldehyde in enriched
PBS pH 6.1 for 1 min at room temperature and methanol at 18 1C for at least 1 h. Non-speciﬁc binding
of antibodies was blocked by incubation with goat serum (Sigma-Aldrich) for 1 h at 37 1C. Cells were
stained with anti-α-tubulin (Sigma-Aldrich, 1:500 in 1% bovine serum albumin containing PBS) for the
evaluation of cell morphology and the detection of freshly divided cells, and with anti-centromere
protein antibodies (from patients with limited systemic scleroderma/CREST syndrome, Antibodies Inc.,
Davis, CA, USA, 1:100 in 1% bovine serum albumin containing PBS) followed by secondary Cy3-
conjugated goat anti-mouse antibody (Jackson Immune Research Laboratories, Inc., West Grove, USA,
diluted 1:250 in PBS) and FITC-conjugated goat polyvalent anti-human antibody (Sigma-Aldrich, diluted
1:148 in PBS) for 1 h at 37 1C each. Finally, slides were mounted with antifade solution containing 1 mg
40,6-diamidino-2-phenylindole (DAPI)/ml.
2.4.3. Fluorescence microscopic analysis
Slides were coded and analyzed with an Observer Z1 ﬂuorescence microscope (Zeiss, Germany)
equipped with a Plan-Apochromat objective 63x/1.4 Oil DIC by a person not knowing the code.
Scoring criteria for micronuclei [15] were considered, supplemented by the following: nucleus and
micronucleus/micronuclei were to lie within the same cytoskeleton (i.e. α-tubulin staining). Moreover,
normal and disrupted mitotic stages, freshly divided cells (i.e. cells with cytoplasmic bridges) as well
as nuclear fragmentation and apoptotic cells were scored (see exemplary micrographs next section).
On each slide, nuclei and micronuclei were visualized using ultraviolet excitation (characteristics of
excitation ﬁlter, beam splitter, and emission ﬁlter were EX G 365, BS FT 395, EM BP 445/50, respectively)
and the microtubules (forming the cytoplasmic microtubule complex, the midbody and the mitotic
spindle) and signals of centromere proteins were analyzed under green (EX BP 550/25, BS FT 570, EM BP
605/70) and blue (EX BP 470/40, BS FT 495, EM BP 525/50) excitation, respectively. All signals were
visualized simultaneously by means of a triple bandpass ﬁlter (EX TBP 406þ489þ561; BS TFT
427þ503þ578; EM TBP 459þ525þ608). At least 1000 cells or 100 cells with micronuclei were scored
per slide with respect to micronuclei, morphology of mitosis, cell divisions and signs of cytotoxicity such
as nuclear fragmentation, apoptotic bodies, and depolymerized cytoplasmic microtubule complex.
2.4.4. Exemplary micrographs of endpoints scored microscopically
Micrographs were taken using AxioCam MRm3 S/N 5925 digital camera controlled by ZEN pro
2011 software (Zeiss, Germany). Each event was photographed with the optical ﬁlter set speciﬁc for
DAPI ﬂuorescence of DNA, Cy3 ﬂuorescence of α-tubulin, and, in some cases, FITC ﬂuorescence of
centromere proteins, using 37 Z-Stacks (i.e. focal planes). Exposure time was set individually to use
maximum dynamic range indicated by the histogram. Calibration bars were added to original.czi ﬁles
using Insert Scale Bar function of the ZEN desk 2012 software (Zeiss). Then, Z-Stacks were reduced to
one plane by the algorithm Extended Depth of Focus using the variants Contrast,Wavelets or Variance as
appropriate. Alternatively, a single Z-Plane was chosen. If image sections were needed, they were
generated using Create Image Subset.
To generate overlays, micrographs of the same event taken with different optical ﬁlter sets, were
merged using Add Channels. Channels were colored individually light blue (DNA), orange/red (α-
tubulin), and – when applicable – green (centromere proteins).
A. Schefﬂer et al. / Data in Brief 4 (2015) 474–487482Normal interphase cells
Each nucleus lies within a single cytoplasmic microtubule complex (CMTC). Intact microtubuli are
oriented from the microtubule organizing center (usually indicated by the highest ﬂuorescence
intensity of α-tubulin staining within the CMTC) towards the cell membrane.
Nuclear fragmentation without and with chromatin condensation
Panel 1 and 2: One (a) or multiple (b) nuclear fragments without chromatin condensation lie
within an intact CMTC. In the latter case, no apparent main nucleus is discernible.
Panel 3: Besides fragmentation of the nucleus, apoptosis is indicated by condensed chromatin
(bright DAPI staining of DNA, encircled) and depolymerized microtubules (encircled). DAPI
ﬂuorescence indicates a micronucleus (MN?), which is disproved by lack of a main nucleus within
the same cytoplasmic microtubule complex.
A. Schefﬂer et al. / Data in Brief 4 (2015) 474–487 483Micronucleated cells Panel 1: The micronucleus (MN) lies together with an obvious main nucleus within the CMTC of a
single cell indicated by a single microtubule organizing center. Panel 2: Remnants of the midbody identify daughter nuclei formed during a recent cytokinesis.
Thus, each of the two micronuclei visible belongs to one of the two daughter cells. Panel 3: Signals of immunochemically stained centromere proteins identify MN containing whole
chromosomes. Thus in panel 3, the MN on the left contains a whole chromosome (MNþ) and the
MN on the right contains a chromosomal fragment (MN-).
A. Schefﬂer et al. / Data in Brief 4 (2015) 474–487484Normal mitotic stages and interphase cells
a—prophase; b—metaphase; c—anaphase I; d—anaphase II; e—telophase; f—two daughter cells formed during a recent cell
division identiﬁed by remnants of the midbody indicating position of cytokinesis.
Disrupted mitotic stages
Metaphases with disrupted mitotic spindles
A. Schefﬂer et al. / Data in Brief 4 (2015) 474–487 485Encircled mitotic spindles contain less and/or shorter and/or disorganized microtubules and/or are
monopolar; most likely leading to polyploidy or mitotic catastrophe. More examples are visible in the
micrographs shown at “Asymmetric cell divisions…” panels 2, 4, and 5, circles c.
Metaphases with tri- and multipolar mitotic spindles
Chromosomes are oriented between three or more spindle poles (arrows).
A. Schefﬂer et al. / Data in Brief 4 (2015) 474–487486Asymmetric cell divisions caused by ana- and telophases with tri- and multipolar mitotic spindles
and lagging chromosomes
Panels 1 and 2, circles a:
Chromosomes are oriented between three or more spindle poles. Depending on the distribution of
the other chromosomes, lagging chromosomes (LC) might appear as one of several “nuclei”
distributed evenly or unevenly between two or more daughter cells, in some cases meeting the
criteria for micronuclei.
Panels 1, 3, 4, and 5, circles b:
A. Schefﬂer et al. / Data in Brief 4 (2015) 474–487 487Possible results of asymmetrical mitotic spindle assembly. Chromatin is distributed unevenly
between several “nuclei” of different sizes which lie within 2 to 3 daughter cells as identiﬁed by
remnants of the midbody indicating position of previous cytokinesis (arrows).
Panels 2, 4, and 5 circle c:
Disrupted mitotic spindles in (pro-)metaphase.Appendix A. Supporting information
Supplementary data associated with this article can be found in the online version at http://dx.doi.
org/10.1016/j.dib.2015.07.010.References
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